Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
12 drugs in development
By Therapeutic Area
top 3
R&D Momentum
77/100
Pipeline Velocity
48/100
Trial Completion Rate
76/100
Pipeline Concentration
31/100
Pipeline Freshness
57/100
Strategic Signals
Activity
Last 14 days
A Low-Cost, Scalable Treatment Strategy for Improving Hypertension Control in Low and Middle-Income Settings: Formative Phase (Aim 1)
Breath Research Narrow Validation for Gastrointestinal Cancer Detection
Pilot Study of EMG-Directed Virtual-Reality Experience Training for Motor Stroke Rehabilitation
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)